Annotated Medicine and Device Lists


Rifampicin

This medicine is present in:

List Section Observation
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. Anti-Infectives Antituberculosis No observations
Bolivia. Lista Nacional de Medicamentos Esenciales 2018-2020 04 ANTIMICOBACTERIAS No observations
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 07.03 ANTITUBERCULAR DRUGS No observations
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 J. ANTI-INFECCIOSOS PARA USO SISTEMICO No observations
Chile. Formulario Nacional de Medicamentos. 2005 06.03. ANTITUBERCULOSOS No observations
Guyana. Essential Medicines List. 2020-2021 7.03. Antileprosy Medicines No observations
Guyana. Essential Medicines List. 2020-2021 Antituberculosis Medicines No observations
Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 8: 16 Antituberculosis agents No observations
Barbados. Barbados National Drug Formulary (BNDF) 08.16.04 Antituberculosis Agents No observations

This medicine is present in:

List Section Observation
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. Anti-Infectives Antituberculosis No observations
Costa Rica. Caja Costarricense de Seguro Social. 2019 03. Antituberculosos No observations
Bolivia. Lista Nacional de Medicamentos Esenciales 2018-2020 04 ANTIMICOBACTERIAS No observations
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 07.03 ANTITUBERCULAR DRUGS No observations
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. Others observations:
X 100 CAPSULAS
Mexico. Cuadro Basico de Medicamentos - 2017 06. ENFERMEDADES INFECCIOSAS Y PARASITARIAS No observations
Mexico. Cuadro Basico de Medicamentos - 2017 06. ENFERMEDADES INFECCIOSAS Y PARASITARIAS No observations
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 J. ANTI-INFECCIOSOS PARA USO SISTEMICO No observations
El Salvador - 2019 ANTIMICOBACTERIANOS No observations
Chile. Formulario Nacional de Medicamentos. 2005 06.03. ANTITUBERCULOSOS No observations
Guyana. Essential Medicines List. 2020-2021 7.03. Antileprosy Medicines No observations
Guyana. Essential Medicines List. 2020-2021 Antituberculosis Medicines No observations
Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 8: 16 Antituberculosis agents No observations
Barbados. Barbados National Drug Formulary (BNDF) 08.16.04 Antituberculosis Agents No observations

This medicine is present in:

List Section Observation
Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 03.02. ANTIBACTERIANOS No observations
Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 03.02. ANTIBACTERIANOS No observations

This medicine is present in:

List Section Observation
Peru 6.2.4 Anti-Tuberculosis No observations
Paraguay. Lista de Medicamentos Esenciales. 2009 04. ANTIMICOBACTERIAS (TUBERCULOSIS Y LEPRA) No observations
Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 8: 16 Antituberculosis agents No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 6.2.5. Antituberculosis medicines This medicine is only for children.
PAHO Strategic Fund Medicine List 2.3. Antituberculosis med. No observations
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 J. ANTI-INFECCIOSOS PARA USO SISTEMICO No observations
Suriname. NGK-C-011 6.06 Anti-tuberculosis agents No observations
Haiti. National List of Essential Medicines 06.02.04 Anti-tuberculosis drugs No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 6.2.4. Antileprosy medicines No observations
WHO Model List of Essential Medicines (2021) 6.2.5. Antituberculosis medicines No observations
PAHO Strategic Fund Medicine List 2.3. Antituberculosis med. No observations
Peru 6.2.3 Anti-Leprosy No observations
Suriname. NGK-C-011 6.06 Anti-tuberculosis agents No observations
Haiti. National List of Essential Medicines 06.02.03 Antileprosy No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 6.2.4. Antileprosy medicines No observations
WHO Model List of Essential Medicines (2021) 6.2.5. Antituberculosis medicines No observations
PAHO Strategic Fund Medicine List 2.3. Antituberculosis med. No observations
Peru 6.2.3 Anti-Leprosy No observations
Peru 6.2.4 Anti-Tuberculosis No observations
Ecuador Essential Medicines List - Ecuador No observations
Suriname. NGK-C-011 6.06 Anti-tuberculosis agents No observations
Haiti. National List of Essential Medicines 06.02.03 Antileprosy No observations
Haiti. National List of Essential Medicines 06.02.04 Anti-tuberculosis drugs No observations

This medicine is present in:

List Section Observation
Ecuador Essential Medicines List - Ecuador No observations
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. Anti-Infectives Antituberculosis No observations
Costa Rica. Caja Costarricense de Seguro Social. 2019 03. Antituberculosos Others observations:
Suspensión Oral. frasco con 60 mL o 120 mL.
Bolivia. Lista Nacional de Medicamentos Esenciales 2018-2020 04 ANTIMICOBACTERIAS No observations
Mexico. Cuadro Basico de Medicamentos - 2017 06. ENFERMEDADES INFECCIOSAS Y PARASITARIAS No observations
El Salvador - 2019 ANTIMICOBACTERIANOS No observations
Chile. Formulario Nacional de Medicamentos. 2005 06.03. ANTITUBERCULOSOS No observations

This medicine is present in:

This medicine is present in:

List Section Observation
Paraguay. Lista de Medicamentos Esenciales. 2009 04. ANTIMICOBACTERIAS (TUBERCULOSIS Y LEPRA) No observations
Haiti. National List of Essential Medicines 06.02.04 Anti-tuberculosis drugs No observations

Information Resources: Rifampicin

Loading ...
Loading ...
Loading ...
No information available